146 related articles for article (PubMed ID: 30314969)
1. Aberrant Thyroid-Stimulating Hormone Receptor Signaling Increases VEGF-A and CXCL8 Secretion of Thyroid Cancer Cells, Contributing to Angiogenesis and Tumor Growth.
Song YS; Kim MJ; Sun HJ; Kim HH; Shin HS; Kim YA; Oh BC; Cho SW; Park YJ
Clin Cancer Res; 2019 Jan; 25(1):414-425. PubMed ID: 30314969
[TBL] [Abstract][Full Text] [Related]
2. Thyrotropin (TSH)-induced production of vascular endothelial growth factor in thyroid cancer cells in vitro: evaluation of TSH signal transduction and of angiogenesis-stimulating growth factors.
Hoffmann S; Hofbauer LC; Scharrenbach V; Wunderlich A; Hassan I; Lingelbach S; Zielke A
J Clin Endocrinol Metab; 2004 Dec; 89(12):6139-45. PubMed ID: 15579770
[TBL] [Abstract][Full Text] [Related]
3. Functional thyrotropin receptor attenuates malignant phenotype of follicular thyroid cancer cells.
Hoffmann S; Maschuw K; Hassan I; Wunderlich A; Lingelbach S; Ramaswamy A; Hofbauer LC; Zielke A
Endocrine; 2006 Aug; 30(1):129-38. PubMed ID: 17185801
[TBL] [Abstract][Full Text] [Related]
4. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
Ding C; Li L; Yang T; Fan X; Wu G
BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.
Viglietto G; Romano A; Manzo G; Chiappetta G; Paoletti I; Califano D; Galati MG; Mauriello V; Bruni P; Lago CT; Fusco A; Persico MG
Oncogene; 1997 Nov; 15(22):2687-98. PubMed ID: 9400995
[TBL] [Abstract][Full Text] [Related]
6. Targeting epidermal growth factor receptor 1 signaling in human thyroid-stimulating hormone-independent thyroid carcinoma FRO cells results in a more chemosensitive and less angiogenic phenotype.
Landriscina M; Piscazzi A; Fabiano A; Maddalena F; Costantino E; Farese A; Bufo P; Cignarelli M
Thyroid; 2009 Jun; 19(6):629-37. PubMed ID: 19499990
[TBL] [Abstract][Full Text] [Related]
7. Thyroid-stimulating hormone promotes the secretion of vascular endothelial growth factor in thyroid cancer cell lines.
Soh EY; Sobhi SA; Wong MG; Meng YG; Siperstein AE; Clark OH; Duh QY
Surgery; 1996 Dec; 120(6):944-7. PubMed ID: 8957478
[TBL] [Abstract][Full Text] [Related]
8. CXCL16 positively correlated with M2-macrophage infiltration, enhanced angiogenesis, and poor prognosis in thyroid cancer.
Kim MJ; Sun HJ; Song YS; Yoo SK; Kim YA; Seo JS; Park YJ; Cho SW
Sci Rep; 2019 Sep; 9(1):13288. PubMed ID: 31527616
[TBL] [Abstract][Full Text] [Related]
9. Estrogen-mediated angiogenesis in thyroid tumor microenvironment is mediated through VEGF signaling pathways.
Kamat A; Rajoria S; George A; Suriano R; Shanmugam A; Megwalu U; Prakash PB; Tiwari R; Schantz S
Arch Otolaryngol Head Neck Surg; 2011 Nov; 137(11):1146-53. PubMed ID: 22106242
[TBL] [Abstract][Full Text] [Related]
10. Effects of PTK787/ZK222584, a tyrosine kinase inhibitor, on the growth of a poorly differentiated thyroid carcinoma: an animal study.
Schoenberger J; Grimm D; Kossmehl P; Infanger M; Kurth E; Eilles C
Endocrinology; 2004 Mar; 145(3):1031-8. PubMed ID: 14607854
[TBL] [Abstract][Full Text] [Related]
11. Relationship between preoperative serum TSH levels and expression of VEGF in papillary thyroid carcinoma.
Li J; Teng L; Jiang H
Asia Pac J Clin Oncol; 2014 Jun; 10(2):149-52. PubMed ID: 23718885
[TBL] [Abstract][Full Text] [Related]
12. Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation.
Tuttle RM; Fleisher M; Francis GL; Robbins RJ
J Clin Endocrinol Metab; 2002 Apr; 87(4):1737-42. PubMed ID: 11932308
[TBL] [Abstract][Full Text] [Related]
13. Calcitriol reduces thrombospondin-1 and increases vascular endothelial growth factor in breast cancer cells: implications for tumor angiogenesis.
García-Quiroz J; Rivas-Suárez M; García-Becerra R; Barrera D; Martínez-Reza I; Ordaz-Rosado D; Santos-Martinez N; Villanueva O; Santos-Cuevas CL; Avila E; Gamboa-Domínguez A; Halhali A; Larrea F; Díaz L
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():215-22. PubMed ID: 24120914
[TBL] [Abstract][Full Text] [Related]
14. Aplidin reduces growth of anaplastic thyroid cancer xenografts and the expression of several angiogenic genes.
Straight AM; Oakley K; Moores R; Bauer AJ; Patel A; Tuttle RM; Jimeno J; Francis GL
Cancer Chemother Pharmacol; 2006 Jan; 57(1):7-14. PubMed ID: 16001179
[TBL] [Abstract][Full Text] [Related]
15. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
16. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
Xiong J; Yang Q; Li J; Zhou S
Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
[TBL] [Abstract][Full Text] [Related]
17. Integrin αvβ3-Mediated Effects of Thyroid Hormones on Mesenchymal Stem Cells in Tumor Angiogenesis.
Schmohl KA; Mueller AM; Dohmann M; Spellerberg R; Urnauer S; Schwenk N; Ziegler SI; Bartenstein P; Nelson PJ; Spitzweg C
Thyroid; 2019 Dec; 29(12):1843-1857. PubMed ID: 31816265
[No Abstract] [Full Text] [Related]
18. Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells.
Hoffmann S; Rockenstein A; Ramaswamy A; Celik I; Wunderlich A; Lingelbach S; Hofbauer LC; Zielke A
Mol Cell Endocrinol; 2007 Jan; 264(1-2):74-81. PubMed ID: 17101211
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing CXCL8.
Fang W; Ye L; Shen L; Cai J; Huang F; Wei Q; Fei X; Chen X; Guan H; Wang W; Li X; Ning G
Carcinogenesis; 2014 Aug; 35(8):1780-7. PubMed ID: 24608042
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic effects of CD73-specific siRNA-loaded nanoparticles in breast cancer-bearing mice.
Ghalamfarsa G; Rastegari A; Atyabi F; Hassannia H; Hojjat-Farsangi M; Ghanbari A; Anvari E; Mohammadi J; Azizi G; Masjedi A; Yousefi M; Yousefi B; Hadjati J; Jadidi-Niaragh F
J Cell Physiol; 2018 Oct; 233(10):7165-7177. PubMed ID: 29741783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
